Treatment patterns and health care resources of brentuximab vedotin in patients with relapsed/relapsed Hodgkin lymphoma
Latest Information Update: 10 Jul 2020
At a glance
- Drugs Brentuximab vedotin (Primary)
- Indications Hodgkin's disease
- Focus Adverse reactions; Therapeutic Use
- 10 Jul 2020 New trial record